Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer

Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer

US Patent 11421034 · Granted Aug 23, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IL31-binding polypeptides and uses thereof2025
Method of making afucosylated anti-FGFR2IIIB antibodies2025
CD80 extracellular domain polypeptides and their use in cancer treatment2025
Exosomes for immuno-oncology and anti-inflammatory therapy2025
Preparation of therapeutic exosomes using membrane proteins2025
Exosomes for immuno-oncology and anti-inflammatory therapy2024
Extracellular vesicles for vaccine delivery2024
Medical use of interferon-lambda for the treatment of fibrosis2024
Methods and compositions relating to airway dysfunction2024
Compositions and methods for inhibition of the JAK pathway2023
B7-H4 antibodies and methods of use thereof2023
Anticancer agents2023